Last reviewed · How we verify
NCT05271136
A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum
NA trial testing Anti-aging Serum in Fine Lines in 26 participants. Completed in 13 October 2020.
13 October 2020
Quick facts
| Lead sponsor | Revision Skincare |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 26 |
| Start date | 30 September 2020 |
| Primary completion | 13 October 2020 |
| Estimated completion | 13 October 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Anti-aging Serum
- Facial Moisturizer
- Cleansing Lotion
- Sunscreen — full drug profile →
- Sunscreen — full drug profile →
Conditions studied
- Fine Lines — all drugs for Fine Lines →
- Wrinkle — all drugs for Wrinkle →
- Photoaging — all drugs for Photoaging →
Sponsor
Revision Skincare — full company profile →
Who can join
Adults 30 to 60, female only, with Fine Lines or Wrinkle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This double-blind, randomized, controlled, single-center clinical trial was conducted to assess the efficacy and tolerance of an anti-aging serum to improve moderate overall photodamage and skin fatigue of aging skin after 7 days of twice-daily use when compared to the efficacy of a combination of anti-aging serum and an anti-aging facial moisturizer. A total of 26 female subjects, aged 34-60, completed study participation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05271136
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fine Lines
Currently open trials in the same condition.
- NCT07111156 — A Clinical Study to Test the Safety and Effectiveness of Pinorox® for Improving Visible Signs of Facial Aging Such as Wr · NA · active not recruiting
- NCT06869252 — Autologous Adipose Cells Therapy · Phase 1, PHASE2 · recruiting
- NCT04540900 — A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) fo · Phase 1 · active not recruiting
Other Revision Skincare trials
Trials by the same sponsor.
- NCT07468175 — A 16-week Clinical Study Investigating a Dark Spot Corrector Serum in Women With Moderate Discrete Hyperpigmentation · NA · completed
- NCT07501000 — Evaluation of the Safety and Tolerability of a Brightening Treatment Paired With a Skincare Regimen · NA · completed
- NCT07500623 — Efficacy and Tolerability of a Scalp Serum · NA · completed
- NCT06366503 — Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative · NA · completed
- NCT06633731 — Clinical Case Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment on Healthy Females with Fitzp · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05271136 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Revision Skincare
- Last refreshed: 8 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05271136.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing